CEOS.US CeCors Inc

Consumer Defensive Health Care Equipment & Supplies USA Stocks
0.0037 USD
Close of Nov 14, 2026
0.0012 0.0090
Market cap
USD 1.17M
P/E
-
P/B
-
ROE
-112.1%
Dividend yield
-
Fundamental score
-

Ratios use the latest price and the current fiscal year annualized from 1 quarter up to Mar 2026.

Is CEOS.US undervalued?

Graham number

The Graham number of CeCors Inc cannot be estimated reliably (it needs positive earnings and book value).

Graham number = √(22.5 × EPS × book value per share): the most a defensive investor should pay according to Benjamin Graham. An estimate, not a recommendation to buy or sell. How is it calculated?

CeCors Inc fundamental analysis

No fundamental analysis for CeCors Inc yet.

CeCors Inc stock price

Prices on the chart can differ slightly from the closing prices StockSummer uses for its ratios.

About CeCors Inc

Psykey, Inc. engages in the research, development, and commercialization of entheogenic, adaptogenic, and nootropic ingredients and formulations for its functional product lines. The company also engages in the development of technologies for the composition, bioavailability, and targeted delivery of entheogen-based therapeutics for the psychedelic market. Its retail products include functional mushroom coffees and teas, oral supplements, and single serve drink mixes. The co…

Full company profile